CSPC Pharmaceutical Group (HK:1093) has released an update.
CSPC Pharmaceutical Group Limited has recently purchased 3 million shares at an average price of HK$6.836 per share under its restricted share award scheme, spending approximately HK$20.5 million. This acquisition represents about 0.025% of the company’s total shares in issue and was part of a plan to provide shares for selected participants. The company’s board will continue to evaluate and decide on the distribution of shares and further market purchases.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
